Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Calvin Roberts Insider Profile
4 Followers
Calvin Roberts, Director at Alimera, holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds 200.18K shares in Alimera (Ticker: ALIM).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+46.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Calvin Roberts holds in companies
Most Profitable Insider Trade
Stock:
IVERIC bio
(ISEE)
(ISEE)
Rating:Informative Buy
Date:Jun 14, 2022 - Jun 14, 2023
Return:+304.40%
The most profitable trade made by Calvin Roberts
Calvin Roberts's Trading History
Alimera
Dec 14, 2016
Director
Informative Sell
55.50K
$714.64K
IVERIC bio
Jul 13, 2023
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Calvin Roberts's performance on stock
You May Also Like
Calvin Roberts insider profile FAQ
What is the percentage of profitable transactions made by Calvin Roberts?
The percentage of profitable transactions made by Calvin Roberts is 25%.
What is the average return per transaction made by Calvin Roberts?
The average return per transaction made by Calvin Roberts is 46.30%.
What stocks does Calvin Roberts hold?
Calvin Roberts holds: ALIM, ISEE stocks.
What was Calvin Roberts’s latest transaction?
Calvin Roberts latest transaction was an Uninformative Sell of ―.
What was Calvin Roberts's most profitable transaction?
Calvin Roberts’s most profitable transaction was an Informative Buy of ISEE stock on June 14, 2022. The return on the trade was 304.40%.
What is Calvin Roberts's role in Alimera?
Calvin Roberts's role in Alimera is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.